Momenta Pharmaceuticals, Inc. (MNTA)

[IanFromSI]

Here it is...

CAMBRIDGE, Mass., May 19, 2015 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the pricing of its underwritten public offering of 7,250,000 shares of its common stock at the public offering price of $19.00 per share. Momenta has granted the underwriters an option to purchase up to an additional 1,087,500 shares of its common stock, exercisable for 30 days.